HELEN HARRIS: Open Payments
NPI 1982386074 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 26 payments from 8 companies in 2025. Trend: 2023 $98 · 2024 $265 · 2025 $498
Food & beverage: $445Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $195 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Optinose US, Inc. | 2 | $50 |
| Stryker Corporation | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $23 |
Products named: DUPIXENT, NUCALA, Xhance, XPRESS LOPROFILE, INSPIRE, TULA.
Industry payments across CA — which companies pay providers there.
